Published in J Immunol on July 01, 1976
Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party. BMJ (1993) 1.43
Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol (1995) 1.01
Hyposensitisation to wasp venom in six hours. Br Med J (Clin Res Ed) (1983) 0.86
Decrease of IgE-dependent platelet activation in Hymenoptera hypersensitivity after specific rush desensitization. Clin Exp Immunol (1988) 0.78
Activation of the alternate pathway of human complements by rabbit cells. J Immunol (1974) 5.59
Magnetic control of ferroelectric polarization. Nature (2003) 5.23
Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science (1968) 4.38
Modulation of inflammation and immunity by cyclic AMP. Science (1974) 4.31
The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol (1972) 3.51
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37
Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol (1967) 3.05
Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol (1966) 2.92
Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol (1970) 2.91
Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol (1997) 2.91
Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3',5'-adenosine monophosphate in human leukocytes. J Immunol (1972) 2.70
Distribution of gamma E-forming cells in lymphoid tissues of the human and monkey. J Immunol (1970) 2.66
A reappraisal of sting challenges: to whom should we offer venom immunotherapy? J Allergy Clin Immunol (1994) 2.65
Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol (1966) 2.62
Regulation of IgE synthesis. Annu Rev Immunol (1984) 2.61
Anaphylaxis. N Engl J Med (1991) 2.53
Stimulation of phospholipid methylation, Ca2+ influx, and histamine release by bridging of IgE receptors on rat mast cells. Proc Natl Acad Sci U S A (1980) 2.50
Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release. Science (1971) 2.47
Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol (2001) 2.38
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis (1983) 2.37
The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med (1990) 2.35
Regulation of antibody response in vitro. VI. Carrier-specific helper cells for IgG and IgE antibody response. J Immunol (1973) 2.33
A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N Engl J Med (1974) 2.33
Biologic function of the Fc fragments of E myeloma protein. Immunochemistry (1970) 2.23
Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A (1988) 2.22
Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors. J Immunol (1979) 2.20
Inhibition of histamine release by histamine controlled by H2 receptor. Nature (1973) 2.19
Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses. J Immunol (1976) 2.18
IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol (1995) 2.18
Immunological aspects of allergic asthma. Annu Rev Immunol (1994) 2.17
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
Cellular events in the IgE antibody response. Adv Immunol (1976) 2.16
Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. Prog Allergy (1975) 2.15
Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol (1996) 2.13
A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med (1978) 2.08
Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 2.05
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest (1983) 2.05
A research standard for human serum immunoglobulin E. Bull World Health Organ (1970) 2.05
The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine. J Pharmacol Exp Ther (1975) 2.02
Activation of mast cells for mediator release through IgE receptors. Prog Allergy (1984) 2.01
Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B. J Clin Invest (1972) 1.98
Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic sensitivity. Proc Natl Acad Sci U S A (1974) 1.98
Proteolytic degradation of exocrine and serum immunoglobulins. J Clin Invest (1970) 1.97
IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes. J Immunol (1975) 1.97
Molecular identification of an IgE-dependent histamine-releasing factor. Science (1995) 1.95
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
The immediate allergic response: in vitro separation of antigen activation, decay and histamine release. J Immunol (1971) 1.93
Mechanisms of passive sensitization. 3. Number of IgE molecules and their receptor sites on human basophil granulocytes. J Immunol (1973) 1.87
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med (1985) 1.84
Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med (1968) 1.84
Histamine release from human leukocytes by anti-gamma E antibodies. J Immunol (1969) 1.84
Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors. J Immunol (1978) 1.84
Epidemiology of insect venom sensitivity. JAMA (1989) 1.83
C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody. J Immunol (1966) 1.80
Immunologic and cellular changes accompanying the therapy of pollen allergy. J Clin Invest (1971) 1.80
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol (1971) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody. J Exp Med (1968) 1.77
Reversed type allergic skin reactions by anti-gamma-E-globulin antibodies in humans and monkeys. J Immunol (1968) 1.75
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. J Immunol (1976) 1.74
The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release. J Immunol (1971) 1.73
Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.72
Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies. J Immunol (1965) 1.72
IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest (1978) 1.71
Basophil "releasability" in patients with asthma. Am Rev Respir Dis (1980) 1.70
The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins (1972) 1.67
Physiologic manifestations of human anaphylaxis. J Clin Invest (1980) 1.65
Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J Immunol (1973) 1.63
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Mechanisms of passive sensitization. IV. Dissociation of IgE molecules from basophil receptors at acid pH. J Immunol (1974) 1.62
Immune mechanisms of reversed type reaginic hypersensitivity. J Immunol (1969) 1.61
IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest (1973) 1.58
Routine use of penicillin skin testing on an inpatient service. N Engl J Med (1971) 1.58
Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. Proc Natl Acad Sci U S A (1984) 1.58
Presence of gammaE in nasal washings and sputum from asthmatic patients. J Allergy (1970) 1.56
Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol (1970) 1.56
Natural history of Hymenoptera venom sensitivity in adults. J Allergy Clin Immunol (1997) 1.55
Human reaginic antibodies and immunoglobulin E. J Allergy (1968) 1.55
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther (2000) 1.54
Formation of IgE binding factors by human T lymphocytes. J Immunol (1981) 1.53
Mechanisms of reaginic hypersensitivity and IgE antibody response. Immunol Rev (1978) 1.52
Identification of basophil granulocytes as a site of allergic histamine release. J Immunol (1972) 1.52
In vitro studies of human reaginic allergy. Adv Immunol (1968) 1.50
Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. Proc Natl Acad Sci U S A (1990) 1.49
Development of mast cells in vitro. II. Biologic function of cultured mast cells. J Immunol (1977) 1.48
Surface IgE on human basophils during histamine release. J Exp Med (1973) 1.48